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     1) Experimental schedule attemptingto prevent secondary disease by preceding thymec-
 tomy was presented. 
    2) It was confirmed that the thymus played an essential role for establishing adoptive 
 immunity in syngeneic radiation chimeras. 
    3) No effect of preceding thymectomy on survival rates was observed in syngeneic 
 chimeras. 
    4) The procedure appeared to be useful for the suppression of the secondary disease 
 in allogeneic chimeras, bebause the survival rate of thymectomized recipients was better 
 than non-thymectomized one at 45 days after irradiation, and the difference was statistically 
 significant. 
                          INTRODUCTION 
   It has already been shown that the thymus is essential not only for proper 
development of immunological competence in neonatal mice, but also for complete 
recovery from radiation damage of immunological potency in adult mice. In our 
laboratory, experiments have been planned to estimate the role of the thymus 
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played on adoptive immunity in syngeneic radiation chimeras, and on the inci-
dence and pathology of secondary disease in allogeneic ones. 
   The experimental schedule is illustrated in Fig. 1. If thymectomized mice 
fail to recover immunological competence from radiation damage, the following 
possibilities are considered. When these immunologically incompetent mice are 
used as donors for allogeneic bone marrow transplantation, graft-versus-host 
reaction (GVHR) may be protected. On the other hand, if they are used as 
recipients, bone marrow graft may take easier, and the acquisition of immuno-
logical competence by the precursor cells in graft will not take place, thus again 
GVHR may be prevented. In the present report some results obtained so far 
are to be described. 
                    MATERIALS AND METHODS 
   Animals were female Dd/s, C3H and Na2 inbred strain mice supplied from 
Kyoto University Inbred Animal Center. At the age of 6 to 8 weeks, they were 
thymectomized by means of superior sternotomy and suction. The procedure 
was checked histologically at post-mortem examination. Irradiation was perfor-
med by the Co" gamma-irradiation facility belonging to the Institute for Chemi-
cal Research of Kyoto University. Radiation doses were sublethal (500 R. or 
700 R.) in some control experiments, but mostly were lethal. Lethal doses means 
1000 R. for Dd/s strain mice, and 900 R. for Na2 strain. The facility could deliver 
0.6602 x 105 R/hr. of radiation in January, 1968. The other conditions of irradia-
tion were described elsewhere". Within 4 hours after irradiation, syngeneic or 
allogeneic bone narrow cell suspension in Tyrode's solution was infused intra-
venously. The combination of donor's and recipient's strain, and the cell number 
infused are shown in Tables 1 and 2. 
   Immunological responsiveness were tested by the titration of and-sheep red 
blood cell hemagglutinin and by the survival time of skin allograft. The sheep 
blood in Alsver's solution was purchased from Nakarai Chemicals Ltd., Kyoto. 
As donors of skin allograft, C3H strain mice were used. Experimental animals 
were weighed every two days. The survival rate was compared between the 
thymectomeized chimeras and the non-thymectomized ones. 
                           RESULTS 
1. Syngeneic Chimeras 
   The survival rates of the thymectomized and the non-thymectomized mice 
which were lethally irradiated and treated with syngeneic bone marrow cells 
are summarized in Table 1. The survival rate of thymectomized recipients at 
30 days after irradiation was 82.0 per cent. Difference of 30 day survial between 
the thymectomized group and non-thymectomized one appeared to be negligible, 
and harmful effect of thymectomy on survival rate and body weight changes 
was hardly observed. 
   Recovery of immunological potency from radiation damage was tested with 
two methods as described above. The production of and-sheep RBC hemagglu-
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                     Table 1. Survival rate of syngeneic chimeras. 
                   No. of B. M.No. of living / No. of irradiated (/) 
 Recipient Donor cells infused ---------------------------------- 
                ;< 106days after irradiation                 7 14 21 30 60 90 120 
 Dd/sDd/s 5 to 7 25/25 24/25 24/25 24/25 12/12 4/4 
                          (100) (96.0) (96.0) (96.0) (100) (100) * 
 Thx.Dd/s Dd/s 5 to 7 48/52 44/51 42/50 41/50 18/29 14/23 8/21 
                             (92.3) (86.3) (84.0) (82.0) (62.1) (60.9) (38.1)*
Dd/s—— 33/36 8/36 5/36 1/36 0/36 
                           (91.7) (22.2) (13.9) (2.8) (0) 
    B. M.: Bone marrow. Thx. Dd/s : Thymectomized Dd/s. 
     * Combined data of several groups. Some of them were excluded from the survival 
       study after 30 th day because of using them for other experiments. 
tinin at 7 days after primary sensitization was shown in Fig. 2. Although the 
non-thymectomized mice at 4 weeks after lethal irradiation and syngeneic bone 
marrow transplantation reacted to sheep RBC less than non-irradiated mice, 
their reactivity recovered fully at 7 weeks. The previously thymectomized mice, 
on the other hand, reacted significantly less than non-thymectomized controls 
at 4 weeks, and the weak reactivity continued for as long as 4 months. This 
difference was observed in the experiments with 700 R. irradiation, but not with 
500 R. As shown in Fig. 3, rejection of skin allograft in the thymectomized 
mice was obviously delayed only in the experiment with 1000 R. irradiation. 
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    Fig. 2. Immune response of thymectomized and non-thymectomized mice to sheep 
            RBC after gamma-irradiation (and syngeneic bone marrow treatment). 
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                   mice to skin allograft 4 weeks after gamma-irradiation. 
2. Allogeneic Chimeras 
   Na2 and Dd/s strain mice were used as donors and recipients respectively. 
Abundant informations concerning with this combination have been obtained 
during last 9 years in our laboratory2`6'. The survival rates are summarized 
in Table 2. The survival of the mice treated with 5 to 7 x 106 bone marrow cells 
was poor ; besides, the thymectomized recipients died earlier. The mice treated 
                    Table 2. Survival rate of allogeneic chimeras. 
No of B. M.No. of living / No. of irradiated (°o) 
  Recipient Donor cells infused 
                  106days after irradiation 7 14 21 30 45 60 
 Dd/s Na2 5 to 7 20/21 10/21 10/21 6/21 2/21 2/21 
                              (95.3) (47.6) (47.6) (28.6) (9.5) (9.5)
 Thx.Dd/s Na2 5 to 7 15/18 7/18 4/18 3/18 2/18 1/18 
                              (83.4) (38.9) (22.2) (16.7) (11.1) (5.6)
 Dd/s Na2 18 to 20 37/39 35/37 31/36 18/35 6/34 3/34 
(94.8) (94.6) (86.2) (51.4) (20.2) (8.8) 
 Thx.Dd/s Na2 18 to 20 37/38 31/36 24/35 20/34 15/33 5/33 
(97.4) (86.2) (68.6) (58.8) (45.5) (15.2) 
 Dd/s Thx.Na2 5 to 7 26/26 17/26 8/26 5/26 2/26 1/26 
900R.SBM(100) (65.4) (30.8) (19.4) (7.7) (3.8) 
 Thx.Dd/s Thx.Na2 5 to 7 17/18 12/18 8/18 6/18 6/18 4/18 
900R.S BM(94.5) (66.7) (44.4) (33.3) (33.3) (22.2) 
    Thx. Na2 900 R. SBM.: Thymectomized, 900 R. irradiated and syngeneic bone marrow 
                          transplanted Na2. 
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with 18 to  20  X  106 bone marrow cells survived better. Some differences of sur-
vival rate were observed between the thymectomized recipients and the non-
thymectomized ones in the experiment of transplanting 18 to 20 x 106 cells. The 
survival rate of the thymectomized recipients was lower during the first 4 weeks 
after irradiation, but became better afterwards than that of the non-thymecto-
mized ones. Although the difference at 21 days is statistically insignificant (P= 
0.13), that of 45 days is significant (P=0.02), suggesting GVHR may be suppressed 
by the preceding thymectomy. 
   5 to 7 x106 bone marrow cells obtained from thymectomized, lethally irradia-
ted and syngeneic bone marrow cell transplanted Na2 mice did not save satis-
factorily either thymectomized or non-thymectomized recipients. 
                           DISCUSSION 
   The fact that the thymus plays an important role for adoptive immunity in 
syngeneic radiation chimeras was confirmed in the experiment, as Miller et al.'°-13' 
and many investigators have already shown. 
   The immunologically suppressed chimeras were apprehended to die readily 
from invasions of micro-organisms. In spite of these expectation their survival 
rates were fairly good, and so-called wasting which occurred usually in neonatally 
thymectomized mice was never observed in the present experiment. Perhaps, 
these mice are restrictively immunocompetent from two possible reasons. The 
first, the bone marrow is considered to contain a small number of thymus inde-
pendent precursors of the immunologically competent cell. Because these thymus 
independent precursors may contribute to reconstituting immunological potency 
to some degree in the thymectomized chimeras, they have ability to resist to 
frequent attacks of infections. The second, a small number of imunocompetent 
cells in host's lymphoid tissues have a narrow escape from radiation damage 
and may restore immunological potency of the mice. 
   Many reports14-1°' concerning the effect of preceding thymectomy on allogeneic 
or xenogenic hematopoietic cell transplantation have been presented, but their 
results varied considerably. Van Puttenl" reported a beneficial effect protecting 
the secondary disease in xenogeneic bone marrow transplantation. Simmons 
et a1.15' could not find any effect on the survival rate of allogeneic radiation 
chimeras. Good and others of Minnesota groupl'`1°' demonstrated the promoting 
effect of neonatal thymectomy on the susceptibility to GVHR in the experiments 
of intraperitoneal spleen cell injection. 
   In the present experiment, the effect of thymectomy on the survival rates 
of the allogeneic radiation chimeras was biphasic, if to say daringly. During 
the first 4 weeks after irradiation, the survival rate of thymectomized recipients 
was less than that of non-thymectomized ones, but it became better afterwards. 
Although the former difference is statistically insignificant, the latter is significant. 
This significant difference seems to be caused by the suppression of GVHR in 
the thymectomized chimeras, since the precursor cells are thought to fail to 
acquire immunological competence in thymectomized host. 
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   It is speculated that there are two types of precursors of immunologically 
competent cells in the bone marrow, namely thymus dependent (PCo) and thymus 
independent (PC1), and PCo greatly outnumbers PC1 in the  organ20'. Then the 
thymus is considered to be necessary for the transplanted bone marrow to con-
fer adoptive immunity. However, whether or not the thymus plays the same 
important role in allogeneic bone marrow grafting as in syngeneic one has not 
been settled yetle,21) 
   In the bone marrow of thymectomized syngeneic radiation chimeras, the ratio 
of PC1 to PCo is supposed to be lees than normal. Then, as shown in Fig. 1, 
if these treated mice are selected as candidates of allogeneic bone marrow donors, 
the suppression of GVHR may be more effective. Experiments are now being 
carried out to test these possibilities. 
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